Screening methods for anal cancer in high-risk adults
Part of Cancer clinical trials.
This study is looking at ways to screen for anal cancer in people who are at higher risk, such as those with weakened immune systems or a history of abnormal cells in the lower genital tract. It aims to find better methods for early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 80 years old.
- You must have a weakened immune system (chronic).
- You must have a history of lower genital tract neoplasia (abnormal cells).
- You must not have been treated for high-grade anal lesions within the last 6 months.
- You must not have a history of anal cancer.
- You must not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
This trial checks whether anal cancer screening is useful for women age 40 and older who previously had high-grade vulvar pre-cancer (VIN 2/3) or vulvar cancer. It may help find serious problems earlier in people at higher risk.
This study looks for early anal cell changes in women who have had high-grade HPV-related problems in the cervix, vagina, or vulva. It may help find concerning changes sooner, using a structured screening exam.
This study tests how well a special HPV test (called BD Onclarity™) can find anal cancer or precancer. It is for people at high risk or with known anal abnormalities, and aims to improve early detection.
This study tries to prevent anal cancer in men who have sex with men and are at higher risk due to HIV or PrEP use. It uses a special exam called high-resolution anoscopy to check for early signs.
This trial compares two ways to screen for HPV, a virus linked to anal cancer. People living with HIV will either collect their own sample or have a doctor do it, then switch methods. The goal is to see which is more comfortable and accurate.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.